\
&
Contact us
\
&
Contact us
Published on | 3 months ago
Programmes HealthThe Global Health EDCTP3 Joint Undertaking has recently published its 2025 work programme . The calls for proposals will open in late January with a deadline for short proposals in March 2025 (first stage) and a deadline for full proposals (for succesful consortia) in September 2025.
The work programme includes four calls for proposals covering seven topics, with a total budget of €214 million. A pilot on lump sum contributions in the grant agreements for two call topics is being considered, and more flexible ways of working with contributing partners will be introduced to facilitate increased engagement with Global Health EDCTP3 and forge new and stronger partnerships.
Info days on the new work programme are expected to be organised in the coming weeks. The detailed information will be published on the NCP Flanders website as soon as it is available.
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) is a partnership between the European Union and the European and Developing Countries Clinical Trials Partnership (EDCTP) Association whose members are several EU Member States and Associated countries and several African countries.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
